| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2004 | US20040006122 Methods of treating skin disorders using thio-oxindole derivatives |
| 01/08/2004 | US20040006121 Total synthesis of merrilactone A |
| 01/08/2004 | US20040006120 Administering to a patient in need of such weight loss or treatment an effective amount of an inverse agonist of histamine H3 receptors, with the proviso that inverse agonist is not thioperamide |
| 01/08/2004 | US20040006118 Nf-kb inhibitors |
| 01/08/2004 | US20040006117 Microglia inhibitors for interrupting interleukin 12 and IFN-gamma-mediated immune reactions |
| 01/08/2004 | US20040006116 For therapy of non-insulin dependent diabetes mellitus |
| 01/08/2004 | US20040006115 2-Oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin |
| 01/08/2004 | US20040006112 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 01/08/2004 | US20040006111 Transmucosal delivery of proton pump inhibitors |
| 01/08/2004 | US20040006110 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 01/08/2004 | US20040006109 Proton pump inhibitors and liquid vehicle having a pH greater than 6.5 and a viscosity sufficient to maintain a uniform suspension |
| 01/08/2004 | US20040006106 For therapy of breast cancer in mammals |
| 01/08/2004 | US20040006105 Thrombin receptor antagonists |
| 01/08/2004 | US20040006103 Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains and towards HIV strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors |
| 01/08/2004 | US20040006102 Alkoxy aryl beta2 adrenergic receptor agonists |
| 01/08/2004 | US20040006101 Quinolinone derivatives |
| 01/08/2004 | US20040006100 Administering phenylacetic acid derivative for therapy of Parkinson's disease |
| 01/08/2004 | US20040006099 Amidine compounds |
| 01/08/2004 | US20040006098 Induce cytokine biosynthesis in animals |
| 01/08/2004 | US20040006097 For therapy of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis |
| 01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
| 01/08/2004 | US20040006095 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 01/08/2004 | US20040006094 For prophylaxis of ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event |
| 01/08/2004 | US20040006093 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/08/2004 | US20040006092 Amidine derivatives for treating amyloidosis |
| 01/08/2004 | US20040006091 Therapeutic agents useful for treating or preventing pain |
| 01/08/2004 | US20040006089 For therapy of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome |
| 01/08/2004 | US20040006088 Substituted N-(indole-2-carbonyl) -amides and derivatives as glycogen phosphorylase inhibitors |
| 01/08/2004 | US20040006087 Method of treating cancer using FPT inhibitors and antineoplastic agents |
| 01/08/2004 | US20040006086 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes |
| 01/08/2004 | US20040006083 Pyrazolopyrimidines as therapeutic agents |
| 01/08/2004 | US20040006082 For therapy and prophylaxis of diabetes, diabetic complications, diabetic retinopathy, obesity or asthma, hypoglycemic agent, an improving agent for impaired glucose tolerance, a potentiating agent for insulin sensitivity |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006079 Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040006076 Thiazolyl amide derivatives |
| 01/08/2004 | US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 01/08/2004 | US20040006074 Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer |
| 01/08/2004 | US20040006073 Method of treating attention deficit hyperactivity disorder |
| 01/08/2004 | US20040006072 For therapy of general anxiety disorder, anxiety associated with depression, panic disorder and panic attacks |
| 01/08/2004 | US20040006071 Non-nucleoside reverse transcriptase inhibitors |
| 01/08/2004 | US20040006070 Intraspinal continuous infusion of midazolam hydrochloride for the treatment of pain |
| 01/08/2004 | US20040006069 For therapy inflammatory and immune system disorders such as stroke, myocardial infarction, atherosclerosis, ischemic heart disease, ischemia-reperfusion injury |
| 01/08/2004 | US20040006068 Pyrimidine derivatives |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
| 01/08/2004 | US20040006065 Bicyclic pyrimidinones as coagulation cascade inhibitors |
| 01/08/2004 | US20040006064 For therapy of cancers, leukemias, parasites and as reversal agents of harringtonines |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006060 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative |
| 01/08/2004 | US20040006059 C-nitroso compounds and use thereof |
| 01/08/2004 | US20040006058 As inhibitors of cyclin-dependent kinase 4 (Cdk4); antiproliferative agents; for therapy of cancer, tumors |
| 01/08/2004 | US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders |
| 01/08/2004 | US20040006056 Substituted alkanoic acids |
| 01/08/2004 | US20040006055 Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements |
| 01/08/2004 | US20040006054 Cytotoxic N-unsubstituted indoles and cyclopent(b)indoles and method of making and using same |
| 01/08/2004 | US20040006053 Method of long-term treatment of Graft-Versus-Host Disease using topical active corticosteriods |
| 01/08/2004 | US20040006052 Injection solutions to treat neuropathic symptoms and other sensorimotor disorders that are due to neuromas of the foot or other entrapment neuropathies of peripheral nerves, and method of use |
| 01/08/2004 | US20040006051 Estrogen-linked platinum (II) complexes as anticancer agents |
| 01/08/2004 | US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | US20040006048 For prophylaxis and therapy of illnesses in which lipidperoxidation has role, food, beverages, health |
| 01/08/2004 | US20040006047 Heterocyclic amides, a process for their preparation, compositions comprising them and their use |
| 01/08/2004 | US20040006046 For therapy and prophylaxis of hyperglycemia |
| 01/08/2004 | US20040006044 For therapy and prophylaxis |
| 01/08/2004 | US20040006043 Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents |
| 01/08/2004 | US20040006042 Administering 5-fluorouracil, leucovorin and diaminopyrimidine compound for therapy of cancer |
| 01/08/2004 | US20040006041 Ready-to-use, injectable; stability |
| 01/08/2004 | US20040006032 Vaccination |
| 01/08/2004 | US20040006028 Administering a therapeutically effective amount of a flavin N-oxide; exposing flavin N-oxide to an activator, such that activation of the flavin N- oxide results in damage to the DNA in cancer cells without damage to the DNA in normal cells |
| 01/08/2004 | US20040006027 11-C-substituted derivatives of clarithromycin |
| 01/08/2004 | US20040006026 For use as antibiotics, in therapy of infectious diseases |
| 01/08/2004 | US20040006025 As diabetic-medicine which is easy to synthesize, less toxic and has higher curative effect |
| 01/08/2004 | US20040006023 Intravenous administration of a alpha -halogen- acryloyl distamycin derivative for therapy of tumors |
| 01/08/2004 | US20040006021 Pharmaceutical composition comprising factor Vll polypeptides and tranexamic acid |
| 01/08/2004 | US20040006020 Pharmaceutical composition comprising a factor VII polypeptide and epsilon-aminocaproic acid |
| 01/08/2004 | US20040006012 Microemulsion pre-concentrate comprising a difficultly soluble active agent and a carrier medium comprising 1) a hydrophilic phase which comprises dimethylisosorbide and/or a lower alkyl alkanoic ester, 2) a lipophilic phase, and 3) a surfactant |
| 01/08/2004 | US20040006010 Compositions include a polynucleotide that is linked to an immunomodulatory molecule, which molecule comprises an antigen and may further comprise immunomodulators such as cytokines and adjuvants. The polynucleotide portion of the |
| 01/08/2004 | US20040006007 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
| 01/08/2004 | US20040006005 Treating conditions of insulin resistance, hyperglycemia and/or diabetes. In a broad embodiment, the methods comprise the step of administering to a mammal in need of treatment a therapeutically effective amount of an ILK inhibitor. |
| 01/08/2004 | US20040006004 This invention concerns a method for treating or preventing a disease or disorder related to excessive formation of vascular tissue or blood vessels in a patient, said method comprising administering to said patient an agent affecting the NPY Y2 |
| 01/08/2004 | US20040006002 Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| 01/08/2004 | US20040005998 Producing large lots of final sterile Poly-ICLC suitable for clinical use with reduced toxicity at effective dose levels, and method for using Poly-ICLC to regulate genes, and method for using Poly-ICLC to treat certain human and veterinary |
| 01/08/2004 | US20040005995 This invention relates to a method for reducing the incidences and/or the severity of exacerbations of COPD by administering a phosphodiesterase 4 (PDE4) inhibitor. |
| 01/08/2004 | US20040005830 Microencapsulated fragrances and methods of coating microcapsules |
| 01/08/2004 | US20040005712 Transforming B lymphocytes with Epstein-Barr virus, incubating transformed B lymphocytes with flavin N-oxide photosensitizer, adding non-toxic antioxidant, and exposing lymphocytes to activator such as photoradiation to activate photosensitizer |
| 01/08/2004 | US20040005688 Comprises dishevelled associated kinase (DAK) protein for diagnosis, prevention and treatment of cell proliferative diseases |
| 01/08/2004 | US20040005667 Comprises protein for developing vaccines which prevent chlamydial infections; genetic vaccines |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005621 Method of determining a chemotherapeutic regimen based on ERCC1 expression |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005550 Methods and compositions useful for targeting activated vitronectin receptor alphavbeta3 |
| 01/08/2004 | US20040005538 Crystalline human CR2 protein in complex with C3d, and the three dimensional structure of the crystalline complex. Also disclosed are methods of use of the structure, particularly for structure-based identification of compounds that bind to |
| 01/08/2004 | US20040005370 DHEA and/or a chemical or biological precursor or derivative of the latter, characterized in that it additionally comprises at least one metalloproteinase inhibitor. |
| 01/08/2004 | US20040005368 Enhancing lipolysis and the suppression of appetite are presented. Currently the preferred embodiment has these formulations as two separate compositions because of taste considerations. It is known that the two separate compositions |
| 01/08/2004 | US20040005366 Healthy bone formulation |
| 01/08/2004 | US20040005365 Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same |
| 01/08/2004 | US20040005362 Liquid dosage forms of acid labile drugs |